ArticleERJ open research2024

Beyond type 2 asthma biomarkers: risk stratification for NSAID-exacerbated respiratory disease.

Jacqueline Pérez-Pazos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.